Completed PHASE1 INTERVENTIONAL 1-arm NCT00283075

Mouse Cancer Cell-containing Macrobeads in the Treatment of Human Cancer

Use of Mouse Renal Adenocarcinoma Cell-containing Agarose-agarose Macrobeads in the Treatment of Patients With End-stage, Treatment-resistant Epithelial-derived Cancer

Sponsor: The Rogosin Institute

Conditions Intraabdominal Cancers (Various Types)

Interventions Cancer Macrobead placement in abdominal cavity

Updated 9 times since 2017 Last updated: Jan 7, 2019 Started: Jan 31, 2005 Primary completion: Dec 31, 2012 Completion: Feb 28, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Intraabdominal Cancers (Various Types), this trial is completed. The trial is conducted by The Rogosin Institute and has accumulated 9 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1
Jan 2021 — Dec 2022 [monthly]

Completed PHASE1

▶ Show 4 earlier versions

Feb 2019 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Feb 2019 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Rogosin Institute

Data source: The Rogosin Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States